On the Identifiability of Physiological Models: Optimal Design of Clinical Tests

Abstract Physiological models are mathematical models characterized by a physiologically consistent mathematical structure (defined by the set of equations being used) and a set of model parameters to be estimated in the most precise and accurate way. However, systems in physiology and medicine are typically characterized by poor observability (i.e., possibility for the clinician to observe practically and quantify the relevant phenomena occurring in the body through clinical tests and investigations), high number of interacting and unmeasured variables (as an effect of the complexity of interactions), and poor controllability (i.e., limited capacity to drive the state of the system by acting on decision variables). All these factors may severely hinder the practical identifiability of these models, i.e., the possibility to estimate the set of parameters in a statistically satisfactory way from clinical data. Identifiability is a structural property of a model, but it is also determined by the amount of useful information that can be generated by clinical data. Hence, the importance of designing clinical protocols that allow estimating the model parameters in the quickest and more reliable way. In this chapter, we discuss how the identifiability of a physiological model can be characterized and analyzed, and how identifiability tests and model-based design of experiments (MBDoE) techniques can be exploited to tackle the identifiability issues arising from clinical tests. A case study related to the identification of physiological models of von Willebrand disease from clinical data will be presented where techniques and methods for testing the identifiability of PK models have been used.

[1]  Maria Pia Saccomani,et al.  Parameter identifiability of nonlinear systems: the role of initial conditions , 2003, Autom..

[2]  Xiaohua Xia,et al.  On Identifiability of Nonlinear ODE Models and Applications in Viral Dynamics , 2011, SIAM Rev..

[3]  Heikki Mannila,et al.  Principles of Data Mining , 2001, Undergraduate Topics in Computer Science.

[4]  Z. Ruggeri,et al.  The role of von Willebrand factor in thrombus formation. , 2007, Thrombosis research.

[5]  A. Saltelli,et al.  A quantitative model-independent method for global sensitivity analysis of model output , 1999 .

[6]  H. Pohjanpalo.  System identifiability based on the power series expansion of the solution , 1978 .

[7]  C. Cobelli,et al.  Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. , 1980, The American journal of physiology.

[8]  Maria Rodriguez-Fernandez,et al.  A hybrid approach for efficient and robust parameter estimation in biochemical pathways. , 2006, Bio Systems.

[9]  Massimiliano Barolo,et al.  A general model-based design of experiments approach to achieve practical identifiability of pharmacokinetic and pharmacodynamic models , 2013, Journal of Pharmacokinetics and Pharmacodynamics.

[10]  Daniel E. Zak,et al.  Importance of input perturbations and stochastic gene expression in the reverse engineering of genetic regulatory networks: insights from an identifiability analysis of an in silico network. , 2003, Genome research.

[11]  Kiyoshi Yamaoka,et al.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[12]  E. Walter,et al.  Global approaches to identifiability testing for linear and nonlinear state space models , 1982 .

[13]  T. Rothenberg.  Identification in Parametric Models , 1971 .

[14]  Maria Pia Saccomani,et al.  DAISY: A new software tool to test global identifiability of biological and physiological systems , 2007, Comput. Methods Programs Biomed..

[15]  Lennart Ljung,et al.  On global identifiability for arbitrary model parametrizations , 1994, Autom..

[16]  V. Fedorov,et al.  Optimal Design of Dose Response Experiments: A Model-Oriented Approach , 2001 .

[17]  H. Rabitz,et al.  Similarity transformation approach to identifiability analysis of nonlinear compartmental models. , 1989, Mathematical biosciences.

[18]  James W. T. Yates,et al.  Structural Identifiability of Physiologically Based Pharmacokinetic Models , 2006, Journal of Pharmacokinetics and Pharmacodynamics.

[19]  Massimiliano Barolo,et al.  Optimal design of clinical tests for the identification of physiological models of type 1 diabetes in the presence of model mismatch , 2011, Medical & Biological Engineering & Computing.

[20]  D. Lillicrap,et al.  Von Willebrand disease - phenotype versus genotype: deficiency versus disease. , 2007, Thrombosis research.

[21]  A. Girolami,et al.  Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. , 2002, Blood.

[22]  Sten Bay Jørgensen,et al.  Structural parameter identifiability analysis for dynamic reaction networks , 2008 .

[23]  Sandro Macchietto,et al.  Designing robust optimal dynamic experiments , 2002 .

[24]  Steven P. Asprey,et al.  Toward Global Parametric Estimability of a Large-Scale Kinetic Single-Cell Model for Mammalian Cell Cultures , 2005 .

[25]  J. Jacquez,et al.  Numerical parameter identifiability and estimability: Integrating identifiability, estimability, and optimal sampling design , 1985 .

[26]  J. Banga,et al.  Structural Identifiability of Systems Biology Models: A Critical Comparison of Methods , 2011, PloS one.

[27]  C. Kessler,et al.  Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis , 1996, British journal of haematology.

[28]  T. Brubaker,et al.  Nonlinear Parameter Estimation , 1979 .

[29]  Eric Walter,et al.  Guaranteed Numerical Computation as an Alternative to Computer Algebra for Testing Models for Identifiability , 2003, Numerical Software with Result Verification.

[30]  G. K. Bhattacharyya,et al.  Statistics: Principles and Methods , 1994 .

[31]  Massimiliano Barolo,et al.  A model-based approach to the automatic diagnosis of von Willebrand disease , 2014 .

[32]  Sandro Macchietto,et al.  Statistical tools for optimal dynamic model building , 2000 .

[33]  J. Sweeney,et al.  Intraplatelet von Willebrand factor and ABO blood group. , 1992, Thrombosis research.

[34]  Petre Stoica,et al.  Decentralized Control , 2018, The Control Systems Handbook.

[35]  R. Bellman,et al.  On structural identifiability , 1970 .

[36]  R. Padrini,et al.  Assessment of von Willebrand Factor Propeptide Improves the Diagnosis of von Willebrand Disease , 2011, Seminars in thrombosis and hemostasis.